These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17356129)

  • 1. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
    Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
    Krämer S; Binder E; Loof T; Wang-Rosenke Y; Martini S; Khadzhynov D; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F218-27. PubMed ID: 19439518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.
    Peters H; Martini S; Wang Y; Shimizu F; Kawachi H; Krämer S; Neumayer HH
    Kidney Int; 2004 Oct; 66(4):1434-43. PubMed ID: 15458436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
    Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
    Krämer S; Wang-Rosenke Y; Scholl V; Binder E; Loof T; Khadzhynov D; Kawachi H; Shimizu F; Diekmann F; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F440-9. PubMed ID: 18094032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
    Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
    Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis.
    Peters H; Eisenberg R; Daig U; Liefeldt L; Westenfeld R; Gaedeke J; Krämer S; Neumayer HH
    Kidney Int; 2004 Jun; 65(6):2238-48. PubMed ID: 15149337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate alcohol intake has no impact on acute and chronic progressive anti-thy1 glomerulonephritis.
    Peters H; Martini S; Woydt R; Rückert M; Shimizu F; Kawachi H; Liefeldt L; Krämer S; Neumayer HH
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1105-14. PubMed ID: 12676738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis.
    Peters H; Daig U; Martini S; Rückert M; Schäper F; Liefeldt L; Krämer S; Neumayer HH
    Kidney Int; 2003 Aug; 64(2):509-18. PubMed ID: 12846746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-glycoside of Tripterygium wilfordii Hook. f. reduces proteinuria through improving podocyte slit diaphragm dysfunction in anti-Thy1.1 glomerulonephritis.
    Wan YG; Sun W; Zhen YJ; Che XY; Pu HP; Wang Y; Li M; Ruan JG; Yan QJ
    J Ethnopharmacol; 2011 Jun; 136(2):322-33. PubMed ID: 21570456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.
    Burg M; Ostendorf T; Mooney A; Koch KM; Floege J
    Lab Invest; 1997 Apr; 76(4):505-16. PubMed ID: 9111513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
    Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
    Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
    J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C β inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
    Tokuyama H; Kim S; Zhang Y; Langham RG; Cox AJ; Gow RM; Kelly DJ; Gilbert RE
    Nephrology (Carlton); 2011 Sep; 16(7):649-55. PubMed ID: 21575103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses.
    Papadopoulos D; Rundle J; Patel R; Marshall I; Stretton J; Eaton R; Richardson JC; Gonzalez MI; Philpott KL; Reynolds R
    J Neurosci Res; 2010 Feb; 88(2):346-59. PubMed ID: 19658199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril.
    Krämer S; Loof T; Martini S; Rückert M; Wang Y; Böhler T; Shimizu F; Kawachi H; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F359-68. PubMed ID: 15769934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.
    Wan Y; Gu L; Suzuki K; Karasawa T; Fujioka Y; Han GD; Koike H; Kawachi H; Shimizu F
    Nephron Exp Nephrol; 2005; 99(4):e121-9. PubMed ID: 15722645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.